Cite
Transcriptome profiling of patient derived xenograft models established from pediatric acute myeloid leukemia patients confirm maintenance of FLT3-ITD mutation
MLA
David Finkelstein, et al. “Transcriptome Profiling of Patient Derived Xenograft Models Established from Pediatric Acute Myeloid Leukemia Patients Confirm Maintenance of FLT3-ITD Mutation.” Leukemia & Lymphoma, vol. 58, June 2016, pp. 247–50. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....f51442ad5400f1678337b1c742d3068b&authtype=sso&custid=ns315887.
APA
David Finkelstein, Daelynn R. Buelow, Sheila A. Shurtleff, Sharyn D. Baker, Yong-Dong Wang, Jeffery M. Klco, Jeffrey E. Rubnitz, Christina D. Drenberg, Richard J. Rahija, Stanley Pounds, Hiroto Inaba, & Tanja A. Gruber. (2016). Transcriptome profiling of patient derived xenograft models established from pediatric acute myeloid leukemia patients confirm maintenance of FLT3-ITD mutation. Leukemia & Lymphoma, 58, 247–250.
Chicago
David Finkelstein, Daelynn R. Buelow, Sheila A. Shurtleff, Sharyn D. Baker, Yong-Dong Wang, Jeffery M. Klco, Jeffrey E. Rubnitz, et al. 2016. “Transcriptome Profiling of Patient Derived Xenograft Models Established from Pediatric Acute Myeloid Leukemia Patients Confirm Maintenance of FLT3-ITD Mutation.” Leukemia & Lymphoma 58 (June): 247–50. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....f51442ad5400f1678337b1c742d3068b&authtype=sso&custid=ns315887.